
2025 is shaping up to be a blockbuster year in diabetes care! From smart MDI systems to medications that pull triple duty, the future is looking smarter—and less invasive.
Here are several key advancements we expect to see in 2025.
2025 is shaping up to be a blockbuster year in diabetes care! From smart MDI systems to medications that pull triple duty, the future is looking smarter—and less invasive.
Here are several key advancements we expect to see in 2025.
Dr. E’s 85-year-old patient José came to his last endo appointment with a stellar CGM report. Jose’s download stated that his time in range was 78%, his average glucose was 146 mg/dL, and his estimated A1c was 6.8% without any low blood sugars. But a very important data point was missing from the CGM report’s overview, providing an important reminder for both patients and providers.
read more →When diabetes lives with you day-to-day like a stage five clinger, it can be easy to feel like advancements in care aren’t happening at a fast enough pace. But we’re here to tell you, things are happening! Here’s a short list of some of the progress we saw in 2024, including new pumps, new CGMs, and exciting research studies with promising results.
read more →If you have type 2 diabetes, it’s time to get PUMPED! Insulin pumps are becoming more available for people with T2D, and it’s about time. Never worn a pump before? No problem…Drs. E+P explain how they work, key features, basal and bolus options, current pumps on the market, and a new pump designed for the type 2 community that’s coming soon.
read more →History has been just been made! The first-ever year-long CGM sensor was recently approved by the FDA. The Eversense 365 is an implantable CGM that’s cleared for use in people 18 years and older with type 1 or type 2 diabetes. It offers several unique benefits including on-body vibration alerts and a removable transmitter.
read more →The Dexcom Stelo CGM was FDA-approved in March for adults with type 2 diabetes who are not on insulin, and it’s now available for purchase without a prescription. Stelo sends continuous blood sugar readings to a smartphone 24/7, revealing how food, exercise, and sleep can affect your blood glucose. It’s an empowering tool to help people with T2D better understand how glucose affects their health.
read more →Do you know what the record is for the most CGM sensors launched in the same year by the same company? We don’t either, but Abbott is sure to be in the running. Their latest sensor – the FreeStyle Libre 3 Plus which can integrate with AID systems – is now available with a prescription.
read more →As endocrinologists and people living with type 1 diabetes, Drs. E+P wanted to try Medtronic’s newest AID system after hearing about its new algorithm and SmartGuard feature. Dr. E shares his experience as a patient, and Dr. P offers his thoughts on the device from a provider’s point of view.
read more →Many of us treat our phones like a fifth appendage, but now we can opt to leave our phones at home and still get CGM data. Dexcom recently announced that their G7 CGM can now connect directly to the Apple Watch for users in the U.S, offering people the freedom of real-time glucose readings even when their phone isn’t with them.
read more →The over-the-counter CGM market has two new players…the Lingo and Libre Rio. The two systems created by Abbott were intentionally designed to meet different needs – Lingo for those who want to better understand and improve their health and wellness, and Libre Rio for adults with type 2 diabetes who do not use insulin and typically manage their diabetes through lifestyle modifications.
read more →